Sri Lanka vs Venezuela, Bolivarian Republic of: Laboratories providing drug susceptibility testing (DST)
Sri Lanka
0.2
in 2014
Venezuela, Bolivarian Republic of
0.2
in 2014
Sri Lanka rank
118th
Venezuela, Bolivarian Republic of rank
118th
Laboratories providing drug susceptibility testing (DST) over time
- Sri Lanka
- Venezuela, Bolivarian Republic of
How they compare
Sri Lanka currently reports 0.2 against 0.2 in Venezuela, Bolivarian Republic of, a difference of 0.
The two have swapped places 1 time across 10 shared years of data; in 2005 it was Sri Lanka ahead.
Sri Lanka ranks 118th and Venezuela, Bolivarian Republic of ranks 118th of 157 countries.
Sri Lanka has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Sri Lanka | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.28 | 0.2 | 0.08 | Sri Lanka |
| 2010s | 0.2 | 0.2 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher laboratories providing drug susceptibility testing (dst), Sri Lanka or Venezuela, Bolivarian Republic of?
- Sri Lanka, at 0.2 against 0.2 in Venezuela, Bolivarian Republic of as of 2014.
- What is the difference in laboratories providing drug susceptibility testing (dst) between Sri Lanka and Venezuela, Bolivarian Republic of?
- 0, with Sri Lanka ahead.
- How many years of comparable data are there for Sri Lanka and Venezuela, Bolivarian Republic of?
- 10 years are reported by both, from 2005 to 2014.
- How do Sri Lanka and Venezuela, Bolivarian Republic of rank globally for laboratories providing drug susceptibility testing (dst)?
- Sri Lanka ranks 118th and Venezuela, Bolivarian Republic of ranks 118th of 157 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Laboratories providing drug susceptibility testing (DST) (per 5 million population). Statizoid refreshes it automatically from the source and publishes the full history for both places.